[{"address1": "960 San Antonio Road", "city": "Palo Alto", "state": "CA", "zip": "94303", "country": "United States", "phone": "650 516 4310", "website": "https://www.scilexholding.com", "industry": "Drug Manufacturers - General", "industryKey": "drug-manufacturers-general", "industryDisp": "Drug Manufacturers - General", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Scilex Holding Company focuses on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Its commercial products include ZTlido (lidocaine topical system) 1.8% (ZTlido), a prescription lidocaine topical product for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a ready-to-use oral solution for the acute treatment of migraine with or without aura in adults; and GLOPERBA, a liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults. The company also develops three product candidates, including SP-102 (10 mg, dexamethasone sodium phosphate viscous gel - SEMDEXA), a novel viscous gel formulation of a used corticosteroid for epidural injections, which has completed a phase 3 study to treat lumbosacral radicular pain or sciatica; SP-103 (lidocaine topical system) 5.4%, a formulation of ZTlido for the treatment of chronic neck pain and low back pain (LBP) that has completed a phase 2 trial; and SP-104 (4.5 mg low-dose naltrexone hydrochloride delayed-release capsules), a novel low-dose delayed-release naltrexone hydrochloride, which has completed phase 1 trials for the treatment of fibromyalgia. It has an agreement with Oishi and Itochu to develop lidocaine tape products, including ZTlido and SP-103; and Lifecore Biomedical, LLC for clinical trial material manufacturing and development services for SEMDEXA. Scilex Holding Company is headquartered in Palo Alto, California.", "fullTimeEmployees": 31, "companyOfficers": [{"maxAge": 1, "name": "Dr. Henry H. Ji Ph.D.", "age": 60, "title": "CEO, President & Executive Chairman", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 1261651, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Stephen  Ma", "age": 52, "title": "Senior VP, CFO, COO, Corporate Secretary & Director", "yearBorn": 1972, "fiscalYear": 2024, "totalPay": 613821, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Suketu D. Desai Ph.D.", "age": 59, "title": "Interim Chief Technical Officer & Senior VP", "yearBorn": 1965, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Gigi  DeGuzman", "title": "VP & Chief People Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Suresh K. Khemani", "age": 64, "title": "Senior VP, Chief Commercial Officer & GM of Scilex Pharma", "yearBorn": 1960, "fiscalYear": 2024, "totalPay": 456820, "exercisedValue": 0, "unexercisedValue": 3799157}, {"maxAge": 1, "name": "Dr. Dmitri V. Lissin M.D.", "age": 65, "title": "Senior VP of Clinical Development and Medical Affairs & Interim Chief Medical Officer", "yearBorn": 1959, "fiscalYear": 2024, "totalPay": 528826, "exercisedValue": 0, "unexercisedValue": 3054720}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 16.945, "open": 16.31, "dayLow": 16.31, "dayHigh": 18.98, "regularMarketPreviousClose": 16.945, "regularMarketOpen": 16.31, "regularMarketDayLow": 16.31, "regularMarketDayHigh": 18.98, "payoutRatio": 0.0, "beta": 1.357, "forwardPE": -48.23077, "volume": 119537, "regularMarketVolume": 119537, "averageVolume": 246728, "averageVolume10days": 181410, "averageDailyVolume10Day": 181410, "bid": 18.43, "ask": 19.16, "bidSize": 1, "askSize": 1, "marketCap": 139310800, "fiftyTwoWeekLow": 3.6, "fiftyTwoWeekHigh": 34.27, "allTimeHigh": 591.5, "allTimeLow": 3.6, "priceToSalesTrailing12Months": 3.1492631, "fiftyDayAverage": 20.1039, "twoHundredDayAverage": 12.136775, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 148673728, "profitMargins": -1.79121, "floatShares": 3113582, "sharesOutstanding": 7406210, "sharesShort": 279738, "sharesShortPriorMonth": 563473, "sharesShortPreviousMonthDate": 1757894400, "dateShortInterest": 1760486400, "sharesPercentSharesOut": 0.0378, "heldPercentInsiders": 0.2013, "heldPercentInstitutions": 0.73591006, "shortRatio": 0.93, "shortPercentOfFloat": 0.047399998, "impliedSharesOutstanding": 7406210, "bookValue": -45.292, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -122989000, "trailingEps": -15.54, "forwardEps": -0.39, "lastSplitFactor": "1:35", "lastSplitDate": 1744675200, "enterpriseToRevenue": 3.361, "enterpriseToEbitda": -1.564, "52WeekChange": -0.32905298, "SandP52WeekChange": 0.12121439, "quoteType": "EQUITY", "currentPrice": 18.81, "recommendationKey": "none", "totalCash": 4099000, "totalCashPerShare": 0.746, "ebitda": -95083000, "totalDebt": 49365000, "quickRatio": 0.068, "currentRatio": 0.11, "totalRevenue": 44236000, "revenuePerShare": 5.869, "returnOnAssets": -0.65790004, "grossProfits": 31121000, "freeCashflow": 111761376, "operatingCashflow": 20704000, "revenueGrowth": -0.395, "grossMargins": 0.70352, "ebitdaMargins": -2.14945, "operatingMargins": -2.06265, "financialCurrency": "USD", "symbol": "SCLX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Scilex Holding Company", "longName": "Scilex Holding Company", "marketState": "CLOSED", "exchange": "NCM", "messageBoardId": "finmb_607715156", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "fiftyDayAverageChange": -1.2939014, "fiftyDayAverageChangePercent": -0.064360715, "twoHundredDayAverageChange": 6.6732244, "twoHundredDayAverageChangePercent": 0.5498351, "priceToBook": -0.4153051, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1614954600000, "postMarketChangePercent": -1.1164227, "postMarketPrice": 18.6, "postMarketChange": -0.20999908, "regularMarketChange": 1.865, "regularMarketDayRange": "16.31 - 18.98", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 246728, "corporateActions": [], "postMarketTime": 1762563555, "regularMarketTime": 1762549201, "regularMarketChangePercent": 11.0062, "regularMarketPrice": 18.81, "fiftyTwoWeekLowChange": 15.209999, "fiftyTwoWeekLowChangePercent": 4.225, "fiftyTwoWeekRange": "3.6 - 34.27", "fiftyTwoWeekHighChange": -15.460001, "fiftyTwoWeekHighChangePercent": -0.45112345, "fiftyTwoWeekChangePercent": -32.9053, "earningsTimestampStart": 1762981200, "earningsTimestampEnd": 1762981200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -15.54, "epsForward": -0.39, "epsCurrentYear": -3.51, "priceEpsCurrentYear": -5.3589745, "displayName": "Scilex Holding", "trailingPegRatio": null, "__fetch_time": "2025-11-08"}]